No Detail Found!

Hepatoprotective effect of Acetylated Amino Acid on Methimazole Induced Hepatotoxicity in Mice.

Author(s)
Zunera Hakim Department of Pharmacology, Islamic International Medical College Riphah International University, Islamabad, Pakistan
Akbar Waheed Department of Pharmacology, Islamic International Medical College Riphah International University, Islamabad, Pakistan
Aroosa Ishtiaq Department of Pharmacology Fazaia Medical College, Islamabad, Pakistan
Wardha Mazhar Department of Pharmacology, Foundation University Medical College, Rawalpindi, Pakistan
Abstract
Objective: To explore the hepatoprotective effect of N-acetylcysteine on methimazole induced hepatic damage in mice. Study Design: Randomized control trial. Place and Duration of Study: The study was carried out from Nov 2014 to Oct 2015 at the animal house of Army Medical College, Rawalpindi. Materials and Methods: Thirty male BALB/c mice were randomly divided into three groups of ten animals each. Group I: Control group (C), Group II: Methimazole treated group (M), Group III: Pretreated N-acetylcysteine (NAC) group. Single dose of Methimazole (MMI) (1000mg/kg, i.p) was injected for induction of hepatotoxicity. N-acetylcysteine (NAC) (300mg/kg, i.p) was given pre Methimazole (MMI) administration. The extent of hepatic injury was determined by evaluation of serum alanine transaminase (ALT) and alkaline phosphatase (ALP) along with liver histopathology. Results: Methimazole (MMI) produced liver damage as evident by markedly raised liver enzymes along with necrosis and inflammatory cell infiltration. N-acetylcysteine (NAC) treated group resulted in reduction in elevation of serum biomarkers and improvement of histological picture. Conclusion: N-acetylcysteine (NAC) holds significant hepatoprotective effect against Methimazole (MMI) induced hepatotoxicity.
Publication Details
Page(s) 167-171
DOI DOI not available
Published Journal: Journal of Islamic International Medical College, Volume: 11, Issue: 4, Year: 2016

Request the full text from PASTIC

References
EmilianoAB,GovernaleL,ParksM,CooperDS, 2010.Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008,The Journal of Clinical Endocrinology & Metabolism 95 2227 -33
NakamuraH,NohJY,ItohK,FukataS,MiyauchiA,HamadaN., 2007.Comparison of Methimazole and Propylthiouracil in Patients with Hyperthyroidism Caused by Graves' Disease,The Journal of Clinical Endocrinology & Metabolism 92 2157 -62
WangMT,LeeWJ,HuangTY,ChuCL,HsiehCH, 2014.Antithyroid drug‐related hepatotoxicity in hyperthyroidism patients: a population‐based cohort study,British journal of clinical pharmacology 78 619 -29
HeidariR,BabaeiH,EghbalM., 2013.Mechanisms of methimazole cytotoxicity in isolated rat hepatocytes,Drug and chemical toxicology 36 403 -11
MizutaniT,MurakamiM,ShiraiM,TanakaM,NakanishiK., 1999.Metabolism dependent hepatotoxicity of methimazole in mice depleted of glutathione,Journal of applied toxicology 19 193 -8
LiS,TanHY,WangN,ZhangZJ,LaoL,WongCW, 2015.The Role of Oxidative Stress and Antioxidants in Liver Diseases,International journal of molecular sciences 16 26087 -124
ZafarullahM,LiW,SylvesterJ,AhmadM., 2003.Molecular mechanisms of N‐acetylcysteine actions,Cellular and Molecular Life Sciences CMLS 60 6 -20
RushworthGF,MegsonIL, 2014.Existing and potential therapeutic uses for N‐acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits,Pharmacology & Therapeutics 141 150 -9
KobayashiM,HiguchiS,IdeM,NishikawaS,FukamiT, 2012.N a k a j i m a M , e t a l . T h 2 c y t o k i n e ‐ m e d i a t e d methimazoleinduced acute liver injury in mice,Journal of Applied Toxicology 32 823 -33
HeidariR,BabaeiH,RoshangarL,EghbalMA, 2014.Advanced pharmaceutical bulletin, 4 21 -8
Di PierroF,RossoniG., 2013.An amino acids mixture improves the hepatotoxicity induced by acetaminophen in mice,Journal of amino acids 615754 -
ParasuramanS,RaveendranR,KesavanR, 2010.Blood sample collection in small laboratory animals,Journal of pharmacology & pharmacotherapeutics 1 87 -93
KhanA,WaheedA,ChaudryZA, 2015.Hepatotoxicity; preventive and therapeutic role of dexamethasone in lps/endotoxin induced,Professional Medical Journal 22 1309 -15
DiehlKH,HullR,MortonD,PfisterR,RabemampianinaY,SmithD, 2001.A good practice guide to the administration of substances and removal of blood, including routes and volumes,Journal of Applied Toxicology 21 15 -23
ChenM,BisginH,TongL,HongH,FangH,BorlakJ, 2014.Toward predictive models for drug‐induced liver injury in humans: are we there yet? Biomarkers in medicine, 8 201 -13
HeidariR,NiknahadH,JamshidzadehA,EghbalMA,AbdoliN., 2015.An overview on the proposed mechanisms of antithyroid drugs‐induced liver injury,Advanced pharmaceutical bulletin 5 1 -11
TashkandiBM,SalehHA,JambiHAS, 2014.The Protective Effect of Vitamin E and Selenium on Methimazole‐induced Hepatorenal Toxicity in Adult Rats,Science Journal 11 893 -9
HeidariR,JamshidzadehA,KeshavarzN,AzarpiraN., 2015.Mitigation of Methimazole‐Induced Hepatic Injury by Taurine in Mice,Sci Pharm 83 143 -58
HeidariR,BabaeiH,EghbalMA, 2013.Cytoprotective Effects of Organosulfur Compounds against Methimazole Induced Toxicity in Isolated Rat Hepatocytes,Advanced pharmaceutical bulletin 3 135 -42
DoddS,DeanO,CopolovDL,MalhiGS,BerkM, 2008.Nacetylcysteine for antioxidant therapy: pharmacology and clinical utility, -
MizutaniT,YoshidaK,MurakamiM,ShiraiM,Kawazoe S, 2000.Evidence for the involvement of N‐methylthiourea, a ring cleavage metabolite, in the hepatotoxicity of methimazole in glutathione‐depleted mice: structure‐toxicity and metabolic studies, 13 170 -6
MehtaR,WongL,O'Brien PJ, 2009.Cytoprotective mechanisms of carbonyl scavenging drugs in isolated rat hepatocytes. Chemico‐biological interactions, 178 317 -23
HeidariR,NiknahadH,JamshidzadehA,AzarpiraN,BazyariM,NajibiA, 2015.Carbonyl Traps as Potential Protective Agents against Methimazole‐Induced Liver Injury,Journal of biochemical and molecular toxicology 29 173 -81
0

Citations

0

Downloads

72

Views